AIM
TWST icon

ARK Investment Management’s Twist Bioscience TWST Stock Holding History

ARK Investment Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$468M Sell
4,549,803
-1,792,930
-28% -$117M 3.04% 8
2026
Q1 		$301M Sell
6,342,733
-1,216,762
-16% -$54.6M 2.34% 13
2025
Q4 		$240M Buy
7,559,495
+832,687
+12% +$26M 1.59% 18
2025
Q3 		$189M Buy
6,726,808
+326,367
+5% +$9.89M 1.13% 25
2025
Q2 		$235M Buy
6,400,441
+158,846
+3% +$5.49M 1.73% 15
2025
Q1 		$245M Buy
6,241,595
+645,730
+12% +$29.1M 2.45% 10
2024
Q4 		$260M Buy
5,595,865
+237,772
+4% +$10.7M 2.17% 13
2024
Q3 		$242M Sell
5,358,093
-771,282
-13% -$36.7M 2.21% 13
2024
Q2 		$302M Sell
6,129,375
-814,600
-12% -$33.2M 2.68% 11
2024
Q1 		$238M Sell
6,943,975
-269,282
-4% -$9.72M 1.65% 18
2023
Q4 		$266M Buy
7,213,257
+427,274
+6% +$9.88M 1.57% 19
2023
Q3 		$137M Sell
6,785,983
-173,257
-2% -$3.81M 1.05% 24
2023
Q2 		$142M Sell
6,959,240
-219,872
-3% -$3.29M 0.94% 24
2023
Q1 		$108M Buy
7,179,112
+478,257
+7% +$10.6M 0.74% 24
2022
Q4 		$160M Buy
6,700,855
+23,947
+0.4% +$694K 1.38% 22
2022
Q3 		$235M Buy
6,676,908
+409,187
+7% +$17.4M 1.64% 21
2022
Q2 		$213M Buy
6,267,721
+1,003,466
+19% +$35.5M 1.26% 23
2022
Q1 		$260M Buy
5,264,255
+1,497,052
+40% +$83M 1.09% 24
2021
Q4 		$292M Sell
3,767,203
-179,206
-5% -$18.4M 0.88% 31
2021
Q3 		$422M Sell
3,946,409
-1,108,455
-22% -$127M 1.01% 26
2021
Q2 		$674M Sell
5,054,864
-990,656
-16% -$115M 1.25% 25
2021
Q1 		$749M Buy
6,045,520
+168,549
+3% +$25.6M 1.49% 16
2020
Q4 		$830M Buy
5,876,971
+2,716,493
+86% +$301M 2.21% 9
2020
Q3 		$240M Buy
3,160,478
+1,516,988
+92% +$94.4M 1.42% 21
2020
Q2 		$74.5M Buy
1,643,490
+999,397
+155% +$35.9M 0.8% 33
2020
Q1 		$19.7M Buy
644,093
+245,480
+62% +$6.6M 0.49% 43
2019
Q4 		$8.37M Buy
398,613
+152,986
+62% +$3.58M 0.21% 61
2019
Q3 		$5.87M Buy
245,627
+31,834
+15% +$925K 0.13% 68
2019
Q2 		$6.2M Buy
+213,793
New +$5.66M 0.16% 68

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ARK Investment Management's TWST Position: Q2 2026 in Review

ARK Investment Management reduced its Twist Bioscience (TWST) stake by 28% in Q2 2026, selling an estimated $117M and leaving 4,549,803 shares worth $468M. The position accounts for 3.04% of the portfolio, ranked #8.

ARK Investment Management first reported a position in TWST in Q2 2019 and has held it in 29 quarters since. The position peaked at $830M in Q4 2020. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • ARK Investment Management held 4,549,803 shares of Twist Bioscience worth $468M as of Q2 2026.
  • ARK Investment Management sold 1,792,930 Twist Bioscience shares in Q2 2026, an estimated $117M.
  • Twist Bioscience made up 3.04% of ARK Investment Management's portfolio in Q2 2026, its #8 holding.
  • ARK Investment Management first reported a position in Twist Bioscience in Q2 2019 and has held it in 29 quarters since.
  • ARK Investment Management's Twist Bioscience position peaked at $830M in Q4 2020.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on ARK Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.